Giles GG - Search Results

1

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Doo NW, Giles GG, Southey MC, Milne RL, Offit K, Musinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF. Wang SS, et al. Among authors: giles gg. Cancer Res. 2018 Jul 15;78(14):4086-4096. doi: 10.1158/0008-5472.CAN-17-2900. Epub 2018 May 7. Cancer Res. 2018. PMID: 29735552 Free PMC article.

2

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ. Hopper JL, et al. Among authors: giles gg. Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10498392

3

HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.

Firgaira FA, Seshadri R, McEvoy CR, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Hopper JL. Firgaira FA, et al. Among authors: giles gg. J Natl Cancer Inst. 1999 Dec 15;91(24):2107-11. doi: 10.1093/jnci/91.24.2107. J Natl Cancer Inst. 1999. PMID: 10601382

4

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL. Cui J, et al. Among authors: giles gg. Am J Hum Genet. 2001 Feb;68(2):420-31. doi: 10.1086/318187. Epub 2000 Dec 27. Am J Hum Genet. 2001. PMID: 11133358 Free PMC article.

5

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Among authors: giles gg. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):413-6. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927503

6

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Among authors: giles gg. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010857

7

After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. Jenkins MA, et al. Among authors: giles gg. Int J Cancer. 2002 Nov 10;102(2):166-71. doi: 10.1002/ijc.10670. Int J Cancer. 2002. PMID: 12385013

8

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Dite GS, et al. Among authors: giles gg. J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448. J Natl Cancer Inst. 2003. PMID: 12644538

9

Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL. Cui JS, et al. Among authors: giles gg. Genet Epidemiol. 2003 Apr;24(3):161-72. doi: 10.1002/gepi.10222. Genet Epidemiol. 2003. PMID: 12652520

10

Incidence of ocular melanoma in Australia from 1990 to 1998.

Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Vajdic CM, et al. Among authors: giles gg. Int J Cancer. 2003 May 20;105(1):117-22. doi: 10.1002/ijc.11057. Int J Cancer. 2003. PMID: 12672041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,263 results

Search Page

Filters